Hirsutism

References

• Mofid A, Ahmad S, Alinaghi S, Zandieh S, Yazdani T. Hirsutism. Int J Clin Pract 2008; 62: 433–443
   PubMed Web of Science ®Google Scholar
• Nikolaoua D, Gilling-Smith C. Hirsutism. Curr Obstet Gynaecol 2005; 15: 174–182
   Google Scholar
• Lobo R A, Goebelsmann U, Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 1983; 57: 393–397
   PubMedGoogle Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
   Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
   PubMed Web of Science ®Google Scholar
• Kazer R R, Kessel B, Yen S SC. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1987; 65: 233–236
   PubMedGoogle Scholar
• Futterweit M D, Dunaif A, Yeh H-C, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 1988; 19: 831–836
   PubMed Web of Science ®Google Scholar
• Oláh K S. The modern management of hirsutism. Rev Gynecol Pract 2004; 4: 211–220
   Google Scholar
• Hawkins L A, Chasalow F I, Blethen S L. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J Clin Endocrinol Metab 1992; 74: 248–253
   PubMedGoogle Scholar
• Azziz R, Carmina E, Sawaya M E. Idiopathic hirsutism. Endocrinol Rev 2000; 21: 347–362
   PubMed Web of Science ®Google Scholar
• Hassa H, Mete Tanir H, Yildirim A, Senses T, Eskalen M, Mutlu F S. The hirsutism scoring system should be population specific. Fertil Steril 2005; 84: 778–780
   Google Scholar
• Ferriman D, Galiwey J D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440–1447
   PubMed Web of Science ®Google Scholar
• Stanczyk F Z. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab 2006; 20: 177–191
   PubMed Web of Science ®Google Scholar
• Sahin Y, Kelestimur F. Medical treatment regimens of hirsutism. Reprod Biomed Online 2004; 8: 538–546
   PubMed Web of Science ®Google Scholar
• Koulianos G. Treatment of acne with oral contraceptives: criteria for pill selection. Cutis 2000; 66: 281–286
   PubMed Web of Science ®Google Scholar
• Harper J C. Antiandrogen therapy for skin and hair disease. Dermatol Clin 2006; 24: 137–143
   Google Scholar
• Batukan C, Muderris I I, Ozcelik B, Ozturk A. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism. Gynecol Endocrinol 2007; 23: 38–44
   PubMed Web of Science ®Google Scholar
• Vincenzo D, Giuseppe M, Paola P, Musacchio M C, Petraglia F, Cianci A. Evaluation of effects of an oral contraceptive containing ethinyl estradiol combined with drosperinone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. Fertil Steril 2007; 88: 113–117
   Google Scholar
• Cem B, Ipek M. Efficacy of a new oral contraceptive containing drosperinone and ethinyl estradiol in long term treatment of hirsutism. Fertil Steril 2006; 85: 436–440
   Google Scholar
• Dinger J C, Heinemann L A, Habich D K. The safety of a drosperinone- containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007; 75: 344–354
   PubMed Web of Science ®Google Scholar
• Swiglo B A, Cosma M, Flynn D N, Kurtz D M, Labella M L, Mullan R J, Erwin P J, Montori V M. Antiandrogens for the treatment of hirsutism: a systematic review and meta-analysis of randomised controlled trials. J Clin Endocrinol Metab 2008; 93: 1153–1160
   PubMed Web of Science ®Google Scholar
• Van der Spuy Z M, le Roux P A. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev 2003; 4: CD001125
   Google Scholar
• Farquhar C, Lee O, Toomath R, Jepson R. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2003; 4, CD000194
   Google Scholar
• Beigi A, Sobhi A, Zarrinkoub F. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Int J Gynaecol Obstet 2004; 87: 29–33
   PubMed Web of Science ®Google Scholar
• Sahin Y, Bayram F, Kelestimur F, Muderris I. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. J Endocrinol Invest 1998; 21: 348–352
   PubMed Web of Science ®Google Scholar
• Koulouri O, Conway G S. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf) 2008; 68: 800–805
   PubMed Web of Science ®Google Scholar
• Harborne L, Fleming R, Lyall H, Sattar N, Norman J. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 4116–4123
   PubMed Web of Science ®Google Scholar
• Moghetti P, Toscano V. Treatment of hirsutism and acne in hyperandrogenism. Best Pract Res Clin Endocrinol Metab 2006; 20: 221–234
   PubMed Web of Science ®Google Scholar
• Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003; 101: 995–1007
   PubMed Web of Science ®Google Scholar